Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $0.63.

  • Arcadia Biosciences' EPS (Basic) rose 15338.98% to $0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.72, marking a year-over-year decrease of 391.06%. This contributed to the annual value of -$2.0 for FY2024, which is 8232.16% up from last year.
  • Per Arcadia Biosciences' latest filing, its EPS (Basic) stood at $0.63 for Q3 2025, which was up 15338.98% from -$3.26 recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' EPS (Basic) ranged from a high of $2.33 in Q2 2023 and a low of -$27.3 during Q4 2021
  • Its 5-year average for EPS (Basic) is -$3.36, with a median of -$1.78 in 2024.
  • As far as peak fluctuations go, Arcadia Biosciences' EPS (Basic) plummeted by 745454.55% in 2022, and later soared by 20674.16% in 2025.
  • Arcadia Biosciences' EPS (Basic) (Quarter) stood at -$27.3 in 2021, then soared by 92.98% to -$1.92 in 2022, then fell by 3.38% to -$1.98 in 2023, then surged by 99.0% to -$0.02 in 2024, then skyrocketed by 3281.04% to $0.63 in 2025.
  • Its last three reported values are $0.63 in Q3 2025, -$3.26 for Q2 2025, and $1.9 during Q1 2025.